1.
Levent Doğanay, İlker Sen, Hüseyin Alkım, Ahmet Uyanıkoğlu 0, Kader Irak, Sinem Öztaşkın, et al. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. Turkish Journal of Gastroenterology [Internet]. 2021 Jan. 28 [cited 2025 Jul. 4];31(12):883-9. Available from: https://tjg.avesjournals.com/index.php/tjg/article/view/3971